nodes	percent_of_prediction	percent_of_DWPC	metapath
Methadyl Acetate—OPRM1—TCR Signaling Pathway—CD83—rheumatoid arthritis	0.0656	0.066	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—TNFRSF9—rheumatoid arthritis	0.0497	0.05	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—ICOS—rheumatoid arthritis	0.0285	0.0287	CbGpPWpGaD
Methadyl Acetate—OPRM1—IL4-mediated signaling events—IL4R—rheumatoid arthritis	0.0267	0.0268	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—CD3E—rheumatoid arthritis	0.0206	0.0208	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—ZAP70—rheumatoid arthritis	0.0184	0.0185	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide GPCRs—CX3CR1—rheumatoid arthritis	0.0175	0.0176	CbGpPWpGaD
Methadyl Acetate—OPRM1—IL4-mediated signaling events—ETS1—rheumatoid arthritis	0.0167	0.0168	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—CXCL6—rheumatoid arthritis	0.0157	0.0158	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide GPCRs—CCR6—rheumatoid arthritis	0.0153	0.0154	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—CCL21—rheumatoid arthritis	0.015	0.0151	CbGpPWpGaD
Methadyl Acetate—OPRM1—G-protein activation—POMC—rheumatoid arthritis	0.0143	0.0144	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—NFATC1—rheumatoid arthritis	0.0137	0.0138	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—REL—rheumatoid arthritis	0.0135	0.0136	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—CXCL6—rheumatoid arthritis	0.0132	0.0133	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—CCL21—rheumatoid arthritis	0.0126	0.0127	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—SH2B3—rheumatoid arthritis	0.0124	0.0125	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—TRAF6—rheumatoid arthritis	0.0124	0.0125	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide GPCRs—BDKRB2—rheumatoid arthritis	0.0119	0.012	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—IL17A—rheumatoid arthritis	0.0114	0.0114	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—GATA3—rheumatoid arthritis	0.0111	0.0112	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—CD28—rheumatoid arthritis	0.011	0.0111	CbGpPWpGaD
Methadyl Acetate—OPRM1—Opioid Signalling—ADRBK1—rheumatoid arthritis	0.011	0.011	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL6—rheumatoid arthritis	0.0105	0.0106	CbGpPWpGaD
Methadyl Acetate—OPRM1—IL4-mediated signaling events—IL10—rheumatoid arthritis	0.0104	0.0105	CbGpPWpGaD
Methadyl Acetate—OPRM1—IL4-mediated signaling events—CD40LG—rheumatoid arthritis	0.0104	0.0105	CbGpPWpGaD
Methadyl Acetate—OPRM1—IL4-mediated signaling events—IL4—rheumatoid arthritis	0.0101	0.0102	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL21—rheumatoid arthritis	0.01	0.0101	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—PRKCQ—rheumatoid arthritis	0.0093	0.00935	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—CXCL13—rheumatoid arthritis	0.00925	0.00931	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—CX3CR1—rheumatoid arthritis	0.00825	0.0083	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide GPCRs—CCR5—rheumatoid arthritis	0.00817	0.00822	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CXCL6—rheumatoid arthritis	0.00802	0.00807	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—CXCL13—rheumatoid arthritis	0.00781	0.00785	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—IL1A—rheumatoid arthritis	0.00777	0.00781	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—C5—rheumatoid arthritis	0.00767	0.00771	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CCL21—rheumatoid arthritis	0.00765	0.00769	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—CD8A—rheumatoid arthritis	0.00764	0.00768	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—CCR6—rheumatoid arthritis	0.00721	0.00725	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—CCR5—rheumatoid arthritis	0.00699	0.00703	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—FAS—rheumatoid arthritis	0.00692	0.00696	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—CXCL2—rheumatoid arthritis	0.00659	0.00663	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—CCL3—rheumatoid arthritis	0.00659	0.00663	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—C5—rheumatoid arthritis	0.00647	0.00651	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—CX3CR1—rheumatoid arthritis	0.00646	0.00649	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—SAA1—rheumatoid arthritis	0.00645	0.00649	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL13—rheumatoid arthritis	0.00621	0.00624	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—CCR6—rheumatoid arthritis	0.00608	0.00612	CbGpPWpGaD
Methadyl Acetate—OPRM1—Opioid Signalling—POMC—rheumatoid arthritis	0.00594	0.00597	CbGpPWpGaD
Methadyl Acetate—Loperamide—POMC—rheumatoid arthritis	0.00568	1	CrCbGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—CCR6—rheumatoid arthritis	0.00564	0.00568	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—BDKRB2—rheumatoid arthritis	0.00561	0.00564	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—CXCL12—rheumatoid arthritis	0.00561	0.00564	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—CXCL2—rheumatoid arthritis	0.00556	0.00559	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CX3CR1—rheumatoid arthritis	0.00553	0.00556	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—SAA1—rheumatoid arthritis	0.00544	0.00547	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—C5—rheumatoid arthritis	0.00514	0.00517	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—CXCL10—rheumatoid arthritis	0.00495	0.00498	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR6—rheumatoid arthritis	0.00484	0.00486	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—BDKRB2—rheumatoid arthritis	0.00473	0.00476	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—CXCL12—rheumatoid arthritis	0.00473	0.00476	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CXCL13—rheumatoid arthritis	0.00473	0.00475	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CXCL6—rheumatoid arthritis	0.00453	0.00456	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL2—rheumatoid arthritis	0.00442	0.00445	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL3—rheumatoid arthritis	0.00442	0.00445	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—BDKRB2—rheumatoid arthritis	0.00439	0.00441	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—CD4—rheumatoid arthritis	0.00439	0.00441	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—SAA1—rheumatoid arthritis	0.00433	0.00435	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CCL21—rheumatoid arthritis	0.00432	0.00435	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—CCL5—rheumatoid arthritis	0.00427	0.00429	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CX3CR1—rheumatoid arthritis	0.00421	0.00424	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—CXCL10—rheumatoid arthritis	0.00418	0.0042	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CXCL6—rheumatoid arthritis	0.00412	0.00414	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—IL1B—rheumatoid arthritis	0.00405	0.00407	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CCL21—rheumatoid arthritis	0.00393	0.00395	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—C5—rheumatoid arthritis	0.00392	0.00394	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—CCR5—rheumatoid arthritis	0.00384	0.00386	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—NFKB1—rheumatoid arthritis	0.00378	0.0038	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL12—rheumatoid arthritis	0.00376	0.00378	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—BDKRB2—rheumatoid arthritis	0.00376	0.00378	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—C3—rheumatoid arthritis	0.00376	0.00378	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—MAPK8—rheumatoid arthritis	0.00372	0.00374	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CCR6—rheumatoid arthritis	0.00368	0.0037	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—CCL5—rheumatoid arthritis	0.0036	0.00362	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—PDE2A—rheumatoid arthritis	0.00343	0.00345	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CXCL2—rheumatoid arthritis	0.00337	0.00339	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CCL3—rheumatoid arthritis	0.00337	0.00339	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—rheumatoid arthritis	0.00332	0.00334	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—SAA1—rheumatoid arthritis	0.00329	0.00331	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—CCR5—rheumatoid arthritis	0.00324	0.00326	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—C3—rheumatoid arthritis	0.00317	0.00319	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—TGFB1—rheumatoid arthritis	0.00315	0.00317	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—PDE2A—rheumatoid arthritis	0.00312	0.00314	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—rheumatoid arthritis	0.00301	0.00303	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—POMC—rheumatoid arthritis	0.003	0.00302	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—CCL2—rheumatoid arthritis	0.00294	0.00296	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—BDKRB2—rheumatoid arthritis	0.00286	0.00288	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CXCL12—rheumatoid arthritis	0.00286	0.00288	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—rheumatoid arthritis	0.00286	0.00288	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CXCL13—rheumatoid arthritis	0.00267	0.00269	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—rheumatoid arthritis	0.00258	0.00259	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—POMC—rheumatoid arthritis	0.00253	0.00255	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CXCL10—rheumatoid arthritis	0.00253	0.00255	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—C3—rheumatoid arthritis	0.00252	0.00253	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CXCL6—rheumatoid arthritis	0.00243	0.00245	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CXCL13—rheumatoid arthritis	0.00243	0.00244	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—IL6—rheumatoid arthritis	0.00237	0.00239	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—CXCL8—rheumatoid arthritis	0.00232	0.00234	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CCL21—rheumatoid arthritis	0.00232	0.00233	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—SYVN1—rheumatoid arthritis	0.00232	0.00233	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—IL2RB—rheumatoid arthritis	0.00229	0.0023	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—TAGAP—rheumatoid arthritis	0.00222	0.00224	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—C5—rheumatoid arthritis	0.00221	0.00223	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CCL5—rheumatoid arthritis	0.00218	0.00219	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CX3CR1—rheumatoid arthritis	0.00216	0.00217	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—IL2RB—rheumatoid arthritis	0.00208	0.00209	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CCR6—rheumatoid arthritis	0.00208	0.00209	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—rheumatoid arthritis	0.00201	0.00203	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—C5—rheumatoid arthritis	0.00201	0.00202	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—rheumatoid arthritis	0.00197	0.00198	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CCR5—rheumatoid arthritis	0.00196	0.00197	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—CXCL8—rheumatoid arthritis	0.00196	0.00197	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—C3—rheumatoid arthritis	0.00192	0.00193	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CXCL2—rheumatoid arthritis	0.0019	0.00191	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CCR6—rheumatoid arthritis	0.00189	0.0019	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—SAA1—rheumatoid arthritis	0.00186	0.00187	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PDE2A—rheumatoid arthritis	0.00184	0.00185	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PLB1—rheumatoid arthritis	0.00176	0.00177	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CXCL2—rheumatoid arthritis	0.00173	0.00174	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CCL3—rheumatoid arthritis	0.00173	0.00174	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—SAA1—rheumatoid arthritis	0.00169	0.0017	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—RBPJ—rheumatoid arthritis	0.00162	0.00163	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CXCL12—rheumatoid arthritis	0.00162	0.00163	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—BDKRB2—rheumatoid arthritis	0.00162	0.00163	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—ADRBK1—rheumatoid arthritis	0.0016	0.00161	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—rheumatoid arthritis	0.00156	0.00157	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—POMC—rheumatoid arthritis	0.00153	0.00154	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—RASGRP1—rheumatoid arthritis	0.00151	0.00152	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CCL2—rheumatoid arthritis	0.0015	0.00151	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—PRKCQ—rheumatoid arthritis	0.00148	0.00149	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—BDKRB2—rheumatoid arthritis	0.00147	0.00148	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CXCL12—rheumatoid arthritis	0.00147	0.00148	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—ADRBK1—rheumatoid arthritis	0.00145	0.00146	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CXCL13—rheumatoid arthritis	0.00143	0.00144	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CXCL10—rheumatoid arthritis	0.00143	0.00144	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—RASGRP1—rheumatoid arthritis	0.00137	0.00138	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—PRKCQ—rheumatoid arthritis	0.00134	0.00135	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CXCL10—rheumatoid arthritis	0.0013	0.00131	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—IRAK1—rheumatoid arthritis	0.00129	0.0013	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—TLE3—rheumatoid arthritis	0.00129	0.0013	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CX3CR1—rheumatoid arthritis	0.00128	0.00128	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CCL5—rheumatoid arthritis	0.00123	0.00124	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—IL2RB—rheumatoid arthritis	0.00123	0.00124	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CSF2—rheumatoid arthritis	0.00121	0.00122	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—C5—rheumatoid arthritis	0.00119	0.00119	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CXCL8—rheumatoid arthritis	0.00119	0.00119	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—MMP3—rheumatoid arthritis	0.00118	0.00119	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—NFATC1—rheumatoid arthritis	0.00117	0.00117	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CCL5—rheumatoid arthritis	0.00112	0.00112	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CCR6—rheumatoid arthritis	0.00112	0.00112	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CCR5—rheumatoid arthritis	0.00111	0.00112	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CSF2—rheumatoid arthritis	0.0011	0.00111	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—IL2RA—rheumatoid arthritis	0.00109	0.0011	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—NCF2—rheumatoid arthritis	0.00109	0.00109	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—C3—rheumatoid arthritis	0.00108	0.00109	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—SH2B3—rheumatoid arthritis	0.00106	0.00106	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—TRAF6—rheumatoid arthritis	0.00106	0.00106	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—GZMB—rheumatoid arthritis	0.00105	0.00106	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CXCL2—rheumatoid arthritis	0.00102	0.00103	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CCL3—rheumatoid arthritis	0.00102	0.00103	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CCR5—rheumatoid arthritis	0.00101	0.00101	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—SAA1—rheumatoid arthritis	0.000999	0.001	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—IL2RA—rheumatoid arthritis	0.000993	0.000998	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—C3—rheumatoid arthritis	0.000984	0.00099	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—NCF1—rheumatoid arthritis	0.000978	0.000983	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CD28—rheumatoid arthritis	0.00094	0.000946	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—UBE2D1—rheumatoid arthritis	0.000885	0.00089	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—BDKRB2—rheumatoid arthritis	0.000868	0.000873	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CXCL12—rheumatoid arthritis	0.000868	0.000873	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—POMC—rheumatoid arthritis	0.000867	0.000872	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—IL6ST—rheumatoid arthritis	0.000861	0.000866	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—ADRBK1—rheumatoid arthritis	0.000858	0.000863	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—RASGRP1—rheumatoid arthritis	0.00081	0.000814	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—SYK—rheumatoid arthritis	0.000807	0.000812	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PRKCQ—rheumatoid arthritis	0.000792	0.000797	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—POMC—rheumatoid arthritis	0.000787	0.000792	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—STAT1—rheumatoid arthritis	0.000778	0.000783	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CCL2—rheumatoid arthritis	0.00077	0.000775	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—IL6R—rheumatoid arthritis	0.000768	0.000772	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CXCL10—rheumatoid arthritis	0.000767	0.000772	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—MMP3—rheumatoid arthritis	0.0007	0.000704	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—TYK2—rheumatoid arthritis	0.000699	0.000703	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PTK2—rheumatoid arthritis	0.000674	0.000677	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CXCL8—rheumatoid arthritis	0.000671	0.000674	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CCL5—rheumatoid arthritis	0.00066	0.000664	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CSF2—rheumatoid arthritis	0.000651	0.000654	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—IL2—rheumatoid arthritis	0.000641	0.000645	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—SPP1—rheumatoid arthritis	0.000612	0.000615	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CXCL8—rheumatoid arthritis	0.000609	0.000612	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CCR5—rheumatoid arthritis	0.000595	0.000598	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—IL2RA—rheumatoid arthritis	0.000586	0.00059	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—IL2—rheumatoid arthritis	0.000582	0.000585	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—C3—rheumatoid arthritis	0.000581	0.000585	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—LEP—rheumatoid arthritis	0.000541	0.000544	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—FN1—rheumatoid arthritis	0.00051	0.000513	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—IL6ST—rheumatoid arthritis	0.000508	0.000511	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CD80—rheumatoid arthritis	0.000489	0.000492	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—POMC—rheumatoid arthritis	0.000465	0.000468	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CCL2—rheumatoid arthritis	0.000455	0.000458	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—IL6R—rheumatoid arthritis	0.000454	0.000456	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—TYK2—rheumatoid arthritis	0.000413	0.000416	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—NOS3—rheumatoid arthritis	0.000406	0.000408	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CXCL8—rheumatoid arthritis	0.00036	0.000362	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—IL2—rheumatoid arthritis	0.000344	0.000346	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—IL6—rheumatoid arthritis	0.000342	0.000344	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—MMP9—rheumatoid arthritis	0.000325	0.000327	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—NFKB1—rheumatoid arthritis	0.000322	0.000324	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—MAPK8—rheumatoid arthritis	0.000316	0.000318	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—VEGFA—rheumatoid arthritis	0.000292	0.000294	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—TGFB1—rheumatoid arthritis	0.000268	0.00027	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—TP53—rheumatoid arthritis	0.000221	0.000222	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—IL6—rheumatoid arthritis	0.000202	0.000203	CbGpPWpGaD
